ACM
CAMP icon

AH Capital Management’s CAMP4 Therapeutics CAMP Stock Holding History

AH Capital Management’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.37M Hold
2,125,339
– – 0.73% 12
2025
Q4 		$13M Hold
2,125,339
– – 0.82% 10
2025
Q3 		$6.38M Hold
2,125,339
– – 0.46% 9
2025
Q2 		$3.08M Hold
2,125,339
– – 0.98% 9
2025
Q1 		$8.5M Hold
2,125,339
– – 1.21% 9
2024
Q4 		$11.1M Buy
+2,125,339
New +$17.5M 1.49% 8

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

AH Capital Management's CAMP Position: Q1 2026 in Review

AH Capital Management held its CAMP4 Therapeutics (CAMP) position steady in Q1 2026 at 2,125,339 shares worth $9.37M. The position accounts for 0.73% of the portfolio, ranked #12.

AH Capital Management first reported a position in CAMP in Q4 2024 and has held it in 6 quarters since. The position peaked at $13M in Q4 2025. 46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • AH Capital Management held 2,125,339 shares of CAMP4 Therapeutics worth $9.37M as of Q1 2026.
  • AH Capital Management left its CAMP4 Therapeutics share count unchanged in Q1 2026.
  • CAMP4 Therapeutics made up 0.73% of AH Capital Management's portfolio in Q1 2026, its #12 holding.
  • AH Capital Management first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • AH Capital Management's CAMP4 Therapeutics position peaked at $13M in Q4 2025.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on AH Capital Management's 13F filing for Q1 2026, filed 15 May 2026.